20/09/2017                                                                                                 

Lonza Introduces the New CytoSMART™ 2 System for Live Cell Imaging read more>> 

Recipharm to make clinical trial cancer candidate for Kancera read mroe>>

FDA's Janet Woodcock: the clinical trials system is 'broken' read more>>

Sanofi tests three-in-one antibody to treat or prevent HIV read more>>

Shire, Shionogi's ADHD drug for adults clears late-stage trial in Japan read more>>

GSK gets FDA approval for key triple therapy inhaler read more>> 

19/09/2017                                                                                                 

AbbVie and Roche plan Venclexta combo filings in leukaemia read more>> 

Teva sells women's health division to tackle $35bn debts read more>>

Planning teams forming as Thermo Fisher completes $7.2bn Patheon acquisition read more>>

New lab space to support CRO’s acceleration into 2018 read more>>

FDA approves Trelegy Ellipta inhaler for GlaxoSmithKline, Innoviva read more>> 

18/09/2017                                                                                                 

Bayer’s rare cancer drug Aliqopa bags speedy approval read more>> 

NICE rejects first-line use of Roche’s Gazyvaro read more>> 

Immunocore and Bill and Melinda Gates Foundation collaboration read more>> 

Novartis' Xolair shows strong retreatment efficacy at Phase 3 in chronic spontaneous urticaria read more>> 

15/09/2017                                                                                                 

QuintilesIMS Announces Launch of Secondary Public Offering and Repurchase of Common Stock read more>> 

FDA clears first-ever medical app that helps kick drug addiction read more>>

FDA approves first-ever biosimilar for cancer treatment read more>> 

Novo highlights key ‘hypo’ data from Tresiba at EASD read more>>

14/09/2017                                                                                                 

Evotec and MaRS Innovation establish Academic Bridge "LAB150" in Toronto read more>> 

Pfizer, Astellas prostate cancer drug promising in late-stage trial read more>>

GSK lines up a shot at a blockbuster market as new CEO prepares to tackle Merck rival head on read more>>

Pfizer boosts Ibrance's class with positive neutropenia data read more>> 

AstraZeneca’s Forxiga displays potential in type 1 diabetes read more>> 

Alexion to Restructure Operations, to Lower Headcount by 20% read more>> 

Roche (RHHBY) Announces Data on Respiratory Drug Esbriet read more>> 

13/09/2017                                                                                                 

Alexion's Headquarters Relocation Stings In New Haven read more>>

Scott Gottlieb is closing a big loophole in the orphan drug law read more>>

FDA grants fast-track designation for Shire's lung drug read more>> 

12/09/2017                                                                                                 

Roche under pressure as second rituximab biosimilar filed in US read more>>

Alexion preps big layoffs and a move to Boston/Cambridge read more>>

Shire gets US FDA fast track designation for lung disease drug read more>> 

Novartis says biosimilar rituximab accepted for review by FDA read more>>

11/09/2017                                                                                                 

PAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments read more>> 

Lonza Consumer Care Launches Online "Survive the BPR™" Knowledge Centre read more>> 

Merck's Keytruda extends survival edge on its bladder cancer rivals read more>> 

GSK exercises global licence option for Adaptimmune’s NY-ESO-1 T-cell therapy read more>>

AstraZeneca lung cancer trial results impress but risks remain, analysts say read more>>

Teva appoints Lundbeck’s Kare Schultz as CEO read more>>

Regeneron and Sanofi receive FDA’s breakthrough therapy status for CSCC treatment with cemiplimab read more>>

Catalent to make opioid withdrawal candidate for US approval read more>>

Sanofi and Regeneron announce positive dupilumab topline results read more>>

24/08/2017                                                                                                 

Lonza to Increase and Expand Capabilities for Drug Product Services for Parenteral Dosage Forms read more>> 

Digital-minded Novartis taps Apple's ResearchKit for smartphone MS study read more>> 

Novartis receives EU approval for breast cancer drug Kisqali read more>>

Roche says FDA grants priority review to hemophilia drug emicizumab read more>>

AstraZeneca drug reduces risk of repeat heart attack by almost a third read more>>

23/08/2017                                                                                                 

GVK BIO RECEIVES BEST LIFE SCIENCES QHSE LEADERSHIP INDIA 2017 read more>> 

GlaxoSmithKline partners with Alibaba for China HPV vaccine market grab read more>>  

NICE rejects thyroid cancer drugs read more>> 

India grants Pfizer patent on pneumonia vaccine in blow to aid group read more>>

Envigo eyes public market capital in Avista merger read more>>

22/08/2017                                                                                                 

Jubilant receives NDA approval for Drax Exametazime read more>> 

PAREXEL and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan read more>> 

AstraZeneca strikes mRNA-based partnership in respiratory disease read more>> 

Novartis launches MS smartphone trial read more>> 

$417 Million Awarded in Suit Tying Johnson’s Baby Powder to Cancer read more>>

Orphan drugs: overcoming barriers to market access read more>>

17/08/2017                                                                                                 

Inaugural Charles River World Congress on Animal Models in Drug Discovery & Development to Explore Trends in Reverse Translational Medicine read more>> 

AZ looks to pay-for-performance to bolster cardio-diabetes franchise read more>>

BASF outlines plans for $50m Mumbai R&D campus read more>> 

Evotec completes Aptuit acquisition read more>>

16/08/2017                                                                                                 

After a slow start, Novartis finally gains market traction with heart drug Entresto read more>> 

Sanofi and Regeneron end ten-year mAb collaboration read more>>

FDA grants orphan drug status to H3 Biomedicine’s cancer treatment read more>>

14/08/2017                                                                                                 

Mylan launches three generic anti-retroviral treatments for HIV patients in Canada read more>>

NICE expands Merck KGaA’s Erbitux reach read more>> 

GSK walks away from Ionis antisense drugs read more>> 

NICE turns down kidney cancer drugs read more>> 

Oxford BioMedica enters Innovate UK-backed agreement read more>> 

10/08/2017         &nb